BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2454902)

  • 1. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients.
    Simpson WJ; Panzarella T; Carruthers JS; Gospodarowicz MK; Sutcliffe SB
    Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1063-75. PubMed ID: 2454902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of 92 patients with locally advanced follicular or papillary thyroid cancer after combined treatment.
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1992 May; 168(5):260-9. PubMed ID: 1598660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
    Mazzaferri EL; Jhiang SM
    Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
    McHenry C; Jarosz H; Lawrence AM; Paloyan E
    Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid cancer. Survival in 148 cases followed for 10 years or more.
    Torres J; Volpato RD; Power EG; Lopez EC; Dominguez ME; Maira JL; Ugarte JA; Martinez VC
    Cancer; 1985 Nov; 56(9):2298-304. PubMed ID: 4052973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian survey of thyroid cancer.
    Simpson WJ; McKinney SE
    Can Med Assoc J; 1985 Apr; 132(8):925-31. PubMed ID: 3978516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy and survival in thyroid tumors].
    Rodari A
    Minerva Med; 1986 Nov; 77(44):2127-30. PubMed ID: 3785730
    [No Abstract]   [Full Text] [Related]  

  • 11. Does extracapsular extension impact the prognosis of papillary thyroid microcarcinoma?
    Chéreau N; Buffet C; Trésallet C; Tissier F; Golmard JL; Leenhardt L; Menegaux F
    Ann Surg Oncol; 2014 May; 21(5):1659-64. PubMed ID: 24394985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.
    Taylor T; Specker B; Robbins J; Sperling M; Ho M; Ain K; Bigos ST; Brierley J; Cooper D; Haugen B; Hay I; Hertzberg V; Klein I; Klein H; Ladenson P; Nishiyama R; Ross D; Sherman S; Maxon HR
    Ann Intern Med; 1998 Oct; 129(8):622-7. PubMed ID: 9786809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary and follicular thyroid carcinoma.
    Schlumberger MJ; Torlantano M
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):601-13. PubMed ID: 11289737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
    Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
    Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients.
    Mazzaferri EL; Young RL
    Am J Med; 1981 Mar; 70(3):511-8. PubMed ID: 7211893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
    Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
    Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and prognostic factors in thyroid carcinoma.
    Joensuu H; Klemi PJ; Paul R; Tuominen J
    Acta Radiol Oncol; 1986; 25(4-6):243-8. PubMed ID: 3030051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differentiated thyroid carcinoma, 1972-1992. Follow-up, detection of recurrences and prognostic factors].
    Obiols G; Simó R; Burgos R; Tresserras R; Galofré P; Masmiquel L; Hernández C; Mesa J
    Med Clin (Barc); 1997 Nov; 109(19):738-43. PubMed ID: 9470182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.